Cargando…
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer
BACKGROUND: Obesity has been associated with an adverse prognosis and reduced efficacy of endocrine therapy in patients with hormone receptor-positive (HR+) breast cancer (BC). This study determines the prognostic and predictive effect of body mass index (BMI) on the disease-free survival (DFS) of p...
Autores principales: | Lammers, Senna W M, Geurts, Sandra M E, van Hellemond, Irene E G, Swinkels, Astrid C P, Smorenburg, Carolien H, van der Sangen, Maurice J C, Kroep, Judith R, de Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, de Roos, Wilfred K, Linn, Sabine C, Imholz, Alexander L T, Smidt, Marjolein L, Vriens, Ingeborg J H, Tjan-Heijnen, Vivianne C G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697786/ https://www.ncbi.nlm.nih.gov/pubmed/37991939 http://dx.doi.org/10.1093/jncics/pkad092 |
Ejemplares similares
-
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial
por: Tjan-Heijnen, Vivianne C.G., et al.
Publicado: (2023) -
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019) -
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019) -
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020) -
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)